phenytoin has been researched along with apomorphine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (70.59) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chadwick, D; Elliott, PN; Jenner, P; Marsden, CD; Reynolds, E | 1 |
| Kacz, D; Stach, R | 1 |
| Klawans, HL; Koller, WC; Nausieda, PA; Weiner, WJ | 1 |
| Getova, D; Markovska, V | 1 |
| Defazio, G; Di Reda, N; Giovine, A; Lanzi, C; Lepore, V; Livrea, P; Pedone, D; Tartaglione, B | 1 |
| McKenzie, GM; Soroko, FE | 1 |
| Horiuchi, M; Ibii, N; Yamamoto, K | 1 |
| Czuczwar, SJ; Kleinrok, Z; Kozicka, M | 1 |
| Fukuda, T; Izumi, K; Kishita, C; Koja, T; Nomoto, M; Shimizu, T | 1 |
| Hakkou, F; Poncelet, M; Simon, P | 1 |
| Bhavsar, VH; Dhumal, VR; Kelkar, VV | 1 |
1 review(s) available for phenytoin and apomorphine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
16 other study(ies) available for phenytoin and apomorphine
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The effect of diphenylhydantoin on central catecholamine containing neuronal systems.
Topics: Animals; Apomorphine; Brain; Catecholamines; Corpus Striatum; Dextroamphetamine; Dopamine; Humans; Limbic System; Male; Motor Activity; Neurons; Phenytoin; Rats; Receptors, Dopamine; Reserpine; Rotation; Stereotyped Behavior; Substantia Nigra | 1977 |
Effect of combined dopaminergic and GABA-ergic stimulation on ouabain-induced epileptiform activity.
Topics: Aminooxyacetic Acid; Animals; Apomorphine; Cerebral Cortex; Drug Combinations; Drug Synergism; Electroencephalography; gamma-Aminobutyric Acid; Hydroxybutyrates; Male; Ouabain; Phenytoin; Rabbits; Receptors, Dopamine; Receptors, Neurotransmitter; Seizures | 1977 |
Clinical and experimental studies of phenytoin-induced hyperkinesias.
Topics: Aged; Animals; Apomorphine; Basal Ganglia; Corpus Striatum; Dextroamphetamine; Disease Models, Animal; Drug Synergism; Dyskinesia, Drug-Induced; Female; Guinea Pigs; Haloperidol; Humans; Hyperkinesis; Male; Middle Aged; Phenytoin; Stereotyped Behavior | 1979 |
Study of the participation of the dopaminergic transmission system in the effects of two newly synthesized barbiturates.
Topics: Animals; Apomorphine; Barbiturates; Catalepsy; Haloperidol; Male; Pentobarbital; Phenytoin; Rats; Receptors, Dopamine; Stereotyped Behavior; Synaptic Transmission | 1988 |
Dopaminomimetic action of diphenylhydantoin in rat striatum: effect on homovanillic acid and cyclic AMP levels.
Topics: Animals; Apomorphine; Corpus Striatum; Cyclic AMP; Dyskinesia, Drug-Induced; Haloperidol; Homovanillic Acid; Humans; Male; Phenylacetates; Phenytoin; Psychoses, Substance-Induced; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1985 |
The effects of apomorphine, (+)-amphetamine and L-dopa on maximal electroshock convulsions--a comparative study in the rat and mouse.
Topics: Amphetamine; Animals; Apomorphine; Dextroamphetamine; Dihydroxyphenylalanine; Electroshock; Lethal Dose 50; Male; Mice; Motor Activity; Pargyline; Phenytoin; Rats; Seizures; Time Factors | 1972 |
[Pharmacology of a 1H-1, 2, 4-triazolyl benzophenone derivative (450191-S), a new sleep-inducer (III). Behavioral study on interactions of 450191-S and other drugs in mice].
Topics: Aminopyrine; Animals; Anti-Anxiety Agents; Apomorphine; Behavior, Animal; Benzodiazepines; Central Nervous System; Central Nervous System Agents; Haloperidol; Hypnotics and Sedatives; Imipramine; Male; Mice; Pentylenetetrazole; Phenytoin; Reserpine; Triazoles | 1984 |
Effect of dopaminergic and GABA-ergic drugs given alone or in combination on the anticonvulsant action of phenobarbital and diphenylhydantoin in the electroshock test in mice.
Topics: Amantadine; Aminooxyacetic Acid; Amphetamine; Animals; Apomorphine; Baclofen; Dopamine; Electroshock; Female; Fluphenazine; gamma-Aminobutyric Acid; Haloperidol; Hydroxybutyrates; Levodopa; Male; Mice; Phenobarbital; Phenytoin; Receptors, Neurotransmitter; Seizures | 1980 |
Phenytoin potentiates methamphetamine-induced behavior in mice.
Topics: Animals; Apomorphine; Behavior, Animal; Brain; Carbamazepine; Drug Synergism; Humans; Male; Methamphetamine; Mice; Mice, Inbred Strains; Motor Activity; Phenytoin; Stereotyped Behavior; Tremor | 1984 |
Psychopharmacological profile of diphenylhydantoin in mice.
Topics: Animals; Apomorphine; Barbital; Behavior, Animal; Blepharoptosis; Drug Interactions; Male; Mice; Motor Activity; Oxotremorine; Phenytoin; Reserpine; Yohimbine | 1984 |
The effect of some anti-epilepsy drugs on enhancement of the monoamine-mediated behavioural responses following the administration of electroconvulsive shocks to rats.
Topics: Animals; Anticonvulsants; Apomorphine; Behavior, Animal; Carbamazepine; Clonidine; Diazepam; Dopamine; Electroshock; Lithium; Male; Norepinephrine; Phenytoin; Rats; Rats, Inbred Strains; Serotonin | 1981 |